Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1% 2% 5% 25% 50% 100% 13C-labeled E. coli protein

ABSTRACT: See metadata.xlsx for detailPan_062822_X1iso5.raw1%_13C_unlabeled_EcoliPan_062822_X2iso5.raw1%_13C_unlabeled_EcoliPan_062822_X3iso5.raw1%_13C_unlabeledEcoliPan_062822_X5.raw2%_13C_labeled_EcoliPan_062822_X6.raw2%_13C_labeled_EcoliPan_062822_X7.raw2%_13C_labeled_EcoliPan_062822_X19.raw5%_13C_labeled_EcoliPan_062822_X21.raw5%_13C_labeled_EcoliPanC_092822_X32.raw5%_13C_labeled_EcoliPan_052322_X09.raw25%_13C_labeled_EcoliPan_052322_X10.raw25%_13C_labeled_EcoliPan_052322_X11.raw25%_13C_labeled_EcoliPan_052322_X13.raw50%_13C_labeled_EcoliPan_052322_X13_iso08.raw50%_13C_labeled_Ecoli_0.8_Da_Isolation_WindowPan_052322_X13_iso15.raw50%_13C_labeled_Ecoli_1.5_Da_Isolation_WindowPan_052322_X14.raw50%_13C_labeled_EcoliPan_052322_X14_iso03.raw50%_13C_labeled_Ecoli_3_Da_Isolation_WindowPan_052322_X14_iso07.raw50%_13C_labeled_Ecoli_7_Da_Isolation_WindowPan_052322_X15.raw50%_13C_labeled_EcoliPanC_102522_X46.raw99%_13C_labeled_EcoliPanC_102522_X47.raw99%_13C_labeled_EcoliPanC_102522_X48.raw99%_13C_labeled_Ecoli

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Escherichia Coli

TISSUE(S): Cell Culture

SUBMITTER: Yi Xiong

LAB HEAD: Chongle Pan

PROVIDER: PXD041414 | Pride | 2024-06-14

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	PanC_092822_X32.raw	Raw
	PanC_102522_X46.raw	Raw
	PanC_102522_X47.raw	Raw
	PanC_102522_X48.raw	Raw
	Pan_052322_X09.raw	Raw

Items per page:

1 - 5 of 29

Similar Datasets

Quantitative Tracking of Isotope Flows in Proteomes of Microbial Communities

Project description:Stable isotope probing (SIP) has been used to track nu- trient flows in microbial communities, but existing pro- tein-based SIP methods capable of quantifying the degree of label incorporation into peptides and proteins have been demonstrated only by targeting usually less than 100 proteins per sample. Our method automatically (i) identi- fies the sequence of and (ii) quantifies the degree of heavy atom enrichment for thousands of proteins from microbial community proteome samples. These features make our method suitable for comparing isotopic differences be- tween closely related protein sequences, and for detect- ing labeling patterns in low-abundance proteins or pro- teins derived from rare community members. The proteomic SIP method was validated using proteome samples of known stable isotope incorporation levels at 0.4%, 50%, and 98%. The method was then used to monitor incorporation of 15 N into established and regrow- ing microbial biofilms. The results indicate organism-spe- cific migration patterns from established communities into regrowing communities and provide insights into me- tabolism during biofilm formation. The proteomic SIP method can be extended to many systems to track fluxes of 13 C or 15 N in microbial communities. Molecular and Cellular Proteomics 10: 10.1074/mcp.M110.006049, 1–11, 2011.

2024-06-14 | PXD041958 | Pride

Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids

Project description:Acetate, propionate and butyrate are the main short-chain fatty acids (SCFAs) that arise from the fermentation of fibers by the colonic microbiota. While many studies focus on the regulatory role of SCFAs, their quantitative role as a catabolic or anabolic substrate for the host has received relatively little attention. To investigate this aspect, we infused conscious mice with physiological quantities of stable isotopes [1-13C]acetate, [2-13C]propionate or [2,4-13C2]butyrate directly into the cecum, which is the natural production site in mice, and analyzed their interconversion by the microbiota as well as their metabolism by the host. Cecal interconversion - pointing to microbial cross-feeding - was high between acetate and butyrate, low between butyrate and propionate and almost absent between acetate and propionate. As much as 62% of infused propionate was used in whole-body glucose production, in line with its role as gluconeogenic substrate. Conversely, glucose synthesis from propionate accounted for 69% of total glucose production. The synthesis of palmitate and cholesterol in the liver was high from cecal acetate (2.8% and 0.7%, respectively) and butyrate (2.7% and 0.9%, respectively) as substrates, but low or absent from propionate (0.6% and 0.0%, respectively). Label incorporation due to chain elongation of stearate was approximately 8-fold higher than de novo synthesis of stearate. Microarray data suggested that SCFAs exert only a mild regulatory effect on the expression of genes involved in hepatic metabolic pathways during the 6h infusion period. Altogether, gut-derived acetate, propionate and butyrate play important roles as substrates for glucose, cholesterol and lipid metabolism. Mice were infused in cecum with stably-labelled isotopes of the three main short chain fatty acids or control solution. After 6 hrs, livers were removed and pooled RNA samples were subjected to gene expression profiling.

2013-10-21 | E-GEOD-45926 | biostudies-arrayexpress

Proteomic analysis of ECM-enriched fraction of breast xenograft and skin tissue from mice injected with 13C-glutamine

Project description:Elevated production of collagen-rich extracellular matrix (ECM) is a hallmark of cancer associated fibroblasts (CAFs) and a central driver of cancer aggressiveness. How to target ECM production to oppose cancer is yet unclear, since targeting CAFs has been shown to restrain but also promote cancer progression. Metabolic rewiring is a second hallmark of CAFs. Here we find that proline, which is a highly abundant amino acid in collagen proteins, is newly synthesised from glutamine to make tumour collagen in breast cancer xenografts, and that its production is increased in breast cancer patient-derived CAFs compared to their matched normal fibroblasts in vitro. PYCR1 is the rate-limiting enzyme for proline synthesis and is highly expressed in the tumour stroma of breast cancer patients and in CAFs. Reducing PYCR1 levels in CAFs is sufficient to reduce collagen production, tumour growth and metastatic spread in vivo and cancer cell proliferation in vitro. Collagen and proline synthesis are enhanced by increased acetyl-CoA levels, which occurs through the epigenetic regulator EP300, and targeting PYCR1 overwrites this epigenetic reprogramming and decreases collagen production. Altogether, we present a previously uncharacterised pathway that supports pro-tumorigenic collagen production in CAFs. We show that PYCR1 and COL1A1 are overexpressed in patients with poor prognosis in several cancer types. PYCR1 is a recognised cancer cell vulnerability and potential target for therapy, hence, our work provides evidence that targeting PYCR1 in tumours may have the additional benefit of halting the production of pro-tumorigenic ECM. Finally, PYCR1 is highly expressed in collagen-producing fibroblasts derived from lungs of idiopathic pulmonary fibrosis patients, suggesting that PYCR1 may also offer therapeutic opportunities in fibrotic diseases.

2022-05-31 | PXD024746 | Pride

Combined Metabolic and Chemical (CoMetChem) labeling using stable isotopes

Project description:Histone acetylation is an important, reversible posttranslational protein modification and hallmark of epigenetic regulation. However, little is known about the dynamics of reversible hisotne acetylation, due to the lack of analytical methods that can capture site-specific acetylation and deacetylation reactions. We present a new approach that combines metabolic and chemical labeling (CoMetChem) using uniformly 13C-labeled glucose and stable isotope labeled acetic anhydride, which allows to quantify site-specific lysine acetylation dynamics in tryptic peptides using high-resolution mass spectrometry.

2021-11-02 | PXD027338 | Pride

Improved MS-based proteomics by the reduction of isotopic composition in vivo

Project description:Reducing the isotopic composition of proteins in vivo improves in-depth, high resolution MS-based quantitative proteomics. We used U-[12C]-glucose as the metabolic precursor of all amino acids in yeast. This substantially increased the peptide monoisotopic ion intensity in bottom-up analyses, greatly improving identification scores and protein sequence coverage, and making it possible to address the dynamics of protein turnover at the proteome scale.

2017-08-24 | PXD005364 | Pride

Characterization of the acetylome associated with rapamycin-induced autophagy in HeLa cells

Project description:Autophagy is a lysosomal-mediated catabolic process that degrades cytoplasmic components to help maintain cellular homeostasis and cell survival during exposure to stress. Lysine acetylation is a reversible post-translational modification that plays an important role in the regulation of diverse cellular processes.

2019-01-02 | PXD005793 | Pride

Protemics of human cell during HHV-6A reactivation

Project description:HHV-6A is a human herpesvirus that integrates into human sub telomeric regions to acquire latency. This latent virus frequently reactivates causing numerous diseases. The project was aimed to understand changes in host cell prteomics upon virus reactivation, which might helpin understanding the pathophysiology of virus reactivation.

2020-04-07 | PXD016211 | Pride

Novel insights into quantitative proteomics from an innovative bottom-up Simple Light Isotope Metabolic (bSLIM) labeling data processing strategy

Project description:The Simple Light Isotope Metabolic labeling (SLIM-labeling) is an inovative method to quantify proteome variations based on an original in vivo labeling strategy. Heterotrophic cells grown on a U-[12C] sole source of carbon synthesize U-[12C]-amino acids which are incorporated into proteins giving rise ultimately to U-[12C]-proteins. This results in a large increase of the intensity of the monoisotope ion of peptides and proteins, and therefore allows higher identification scores and protein sequence coverage in mass spectrometry experiments. The method initially developed for signal processing and quantification of the rate of incorporation of 12C into peptides was based on a multistep process that was found difficult to implement by many laboratories. To overcome these limitations, we developed a new theoretical background to analyze the bottom-up proteomics data using SLIM-labeling (bSLIM) and set simple procedures based on open source software, using dedicated OpenMS modules, and embedded R scripts to process the bSLIM experimental data. These new tools allow both the computation of the 12C abundance in peptides to follow kinetics of protein labeling, and of the molar fraction of unlabeled and 12C-labeled peptides in multiplexing experiments to determine the relative abun-dance of proteins extracted from different biological conditions. The tools also allow us to take into account incomplete 12C labeling as observed in cells with nutritional requirements for non-labeled amino acids. These tools were validated on experimental dataset produced using various yeast strains of Saccharomyces cerevisiae and growth conditions. The workflows are built on the implemen-tation of appropriate calculus modules in a KNIME working environment. These new integrated tools provide a convenient frame-work for a wider use of the SLIM-labeling strategy.

2022-02-15 | PXD021329 | Pride

Training set - Novel insights into quantitative proteomics from an innovative bottom-up Simple Light Isotope Metabolic (bSLIM) labeling data processing strategy

2022-02-16 | PXD021502 | Pride

Open-pFind enables precise, comprehensive and rapid peptide identification in shotgun proteomics, part 1

Project description:Shotgun proteomics has grown rapidly in recent decades, but a large fraction of tandem mass spectrometry (MS/MS) data in shotgun proteomics are not successfully identified. We have developed a novel database search algorithm, Open-pFind, to efficiently identify peptides even in an ultra-large search space which takes into account unexpected modifications, amino acid mutations, semi- or non-specific digestion and co-eluting peptides. Tested on two metabolically labeled MS/MS datasets, Open-pFind reported 50.5‒117.0% more peptide-spectrum matches (PSMs) than the seven other advanced algorithms. More importantly, the Open-pFind results were more credible judged by the verification experiments using stable isotopic labeling. Tested on four additional large-scale datasets, 70‒85% of the spectra were confidently identified, and high-quality spectra were nearly completely interpreted by Open-pFind. Further, Open-pFind was over 40 times faster than the other three open search algorithms and 2‒3 times faster than three restricted search algorithms. Re-analysis of an entire human proteome dataset consisting of ~25 million spectra using Open-pFind identified a total of 14,064 proteins encoded by 12,723 genes by requiring at least two uniquely identified peptides. In this search results, Open-pFind also excelled in an independent test for false positives based on the presence or absence of olfactory receptors. Thus, a practical use of the open search strategy has been realized by Open-pFind for the truly global-scale proteomics experiments of today and in the future.

2018-07-11 | PXD008782 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data